Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention
Authors:
- M.Turan AkayMAM.Turan Akay
- Osman AbbasoǧluOAOsman Abbasoǧlu
- Aygün ErcanAEAygün Ercan
- 1 January 2004
- journal article
- review article
- Published by Elsevier in Cancer Detection Prevention
- Vol. 28 (2) , 127-142
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Topical inhibition of oral carcinoma cell with polymer delivered celecoxibCancer Letters, 2003
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasmsMolecular Carcinogenesis, 1999
- Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2Cell, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2Journal of Cancer Research and Clinical Oncology, 1996
- Dietary linoleic acid‐stimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitorNutrition and Cancer, 1996
- The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposisGastroenterology, 1995
- Prognostic significance of plasma prostaglandin E concentration in patients with head and neck cancerJournal of Cancer Research and Clinical Oncology, 1992